Doctors at UVA Health say new technology is helping reduce that risk for some of their most vulnerable heart patients.
Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.